BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Akebia Therapeutics
AKBA
$252M
| $64.9M | ﹤0.01% |
10,261,147
-319,273
| -3% | -$1.52M |
|
|
ROCC
2202
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $64.8M | ﹤0.01% |
2,136,066
+84,102
| +4% | +$2.24M |
|
2203
Acco Brands
ACCO
$407M
| $64.8M | ﹤0.01% |
6,924,768
+31,725
| +0.5% | +$300K |
|
2204
German American Bancorp
GABC
$1.9B
| $64.6M | ﹤0.01% |
1,813,358
+14,570
| +0.8% | +$487K |
|
2205
Stock Yards Bancorp
SYBT
$2.6B
| $64.5M | ﹤0.01% |
1,571,146
+5,185
| +0.3% | +$206K |
|
2206
PC Connection
CNXN
$2.12B
| $64.4M | ﹤0.01% |
1,296,054
+100,098
| +8% | +$4.64M |
|
|
MSGN
2207
DELISTED
MSG Networks Inc.
MSGN
| $64.2M | ﹤0.01% |
3,689,800
-908,769
| -20% | -$15.1M |
|
2208
Cars.com
CARS
$660M
| $64.2M | ﹤0.01% |
5,252,659
+139,300
| +3% | +$1.63M |
|
|
CRCM
2209
DELISTED
CARE.COM, INC.
CRCM
| $64.2M | ﹤0.01% |
4,269,946
-94,695
| -2% | -$1.14M |
|
|
SWP
2210
DELISTED
Stanley Black & Decker, Inc. Corporate Units
SWP
| $64.1M | ﹤0.01% |
587,270
-57,230
| -9% | -$5.99M |
|
|
BMTC
2211
DELISTED
Bryn Mawr Bank Corp
BMTC
| $64.1M | ﹤0.01% |
1,553,500
+30,548
| +2% | +$1.18M |
|
|
TWOU
2212
DELISTED
2U Inc
TWOU
| $63.9M | ﹤0.01% |
88,795
+3,252
| +4% | +$2.02M |
|
|
PFC
2213
DELISTED
Premier Financial Corp. Common Stock
PFC
| $63.7M | ﹤0.01% |
2,023,138
+67,854
| +3% | +$2.05M |
|
2214
MarineMax
HZO
$788M
| $63.5M | ﹤0.01% |
3,806,353
+10,450
| +0.3% | +$170K |
|
|
AD
2215
Array Digital Infrastructure
AD
$3.05B
| $63.5M | ﹤0.01% |
1,753,076
+496,821
| +40% | +$17.4M |
|
|
FLXN
2216
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $63.4M | ﹤0.01% |
3,064,652
+55,653
| +2% | +$939K |
|
|
DERM
2217
DELISTED
Dermira, Inc.
DERM
| $63.4M | ﹤0.01% |
4,182,738
-148,849
| -3% | -$1.28M |
|
2218
iShares Mortgage Real Estate ETF
REM
$543M
| $63.3M | ﹤0.01% |
1,422,319
+36,519
| +3% | +$1.58M |
|
|
YMAB
2219
DELISTED
Y-mAbs Therapeutics
YMAB
| $62.9M | ﹤0.01% |
2,013,091
+688,524
| +52% | +$20.4M |
|
2220
Washington Trust Bancorp
WASH
$741M
| $62.7M | ﹤0.01% |
1,165,079
+1,216
| +0.1% | +$62.5K |
|
2221
CALL
Halliburton
HAL
$26.6B
| $62.6M | ﹤0.01% |
+2,559,000
| New | +$53.9M |
|
|
MMP
2222
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $62.6M | ﹤0.01% |
995,110
+30,973
| +3% | +$1.93M |
|
2223
CareDx
CDNA
$2.42B
| $62.5M | ﹤0.01% |
2,897,340
-7,679
| -0.3% | -$176K |
|
|
SWT
2224
DELISTED
Stanley Black & Decker, Inc.
SWT
| $62.4M | ﹤0.01% |
+572,693
| New | +$60.3M |
|
2225
Liberty Latin America Class A
LILA
$1.67B
| $62.4M | ﹤0.01% |
5,046,478
+38,570
| +0.8% | +$448K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.